Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis
Status:
Not yet recruiting
Trial end date:
2023-08-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity
of subcutaneous SHR-1314 in Patients with Moderate-to-Severe Plaque Psoriasis